What are the recommended clonazepam dosing guidelines for adults with seizures or anxiety, including starting dose, titration schedule, and maximum daily dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clonazepam Dosing Guidelines

For adults with seizures, start clonazepam at no more than 1.5 mg/day divided into three doses, increase by 0.5-1 mg every 3 days as tolerated, with a maximum of 20 mg/day; for panic disorder, start at 0.25 mg twice daily, increase to the target of 1 mg/day after 3 days, with a maximum of 4 mg/day if needed 1.

Seizure Disorders

Adult Dosing Algorithm

Starting dose:

  • Begin at ≤1.5 mg/day divided into three doses 1
  • This conservative start minimizes CNS depression, particularly when adding to existing anticonvulsants

Titration schedule:

  • Increase by 0.5-1 mg increments every 3 days 1
  • Continue until seizures are controlled or side effects emerge
  • Maintenance dose must be individualized based on response

Maximum dose:

  • 20 mg/day 1

Pediatric Dosing (up to 10 years or 30 kg)

Starting dose:

  • 0.01-0.03 mg/kg/day, not exceeding 0.05 mg/kg/day 1
  • Divide into 2-3 doses to minimize drowsiness

Titration:

  • Increase by no more than 0.25-0.5 mg every third day 1
  • Target maintenance: 0.1-0.2 mg/kg/day
  • Divide into three equal doses when possible; if unequal, give largest dose at bedtime

Geriatric Considerations

Start on low doses with close monitoring 1. The evidence does not provide specific geriatric starting doses, but caution is warranted given increased sensitivity to CNS depressants.

Panic Disorder

Adult Dosing Algorithm

Starting dose:

  • 0.25 mg twice daily 1

Titration to target:

  • Increase to 1 mg/day after 3 days 1
  • This 1 mg/day dose is the optimal target based on fixed-dose studies showing best efficacy-to-side-effect ratio

Further increases if needed:

  • Some patients may benefit from higher doses up to 4 mg/day maximum 1
  • Increase in 0.125-0.25 mg increments twice daily every 3 days
  • Higher doses (2-4 mg/day) were less effective and had more adverse effects in trials, so use cautiously

Practical tip: Consider giving one dose at bedtime to reduce daytime somnolence 1.

Dose Equivalency Context

The 2025 benzodiazepine tapering guideline provides important context for understanding clonazepam dosing 2:

  • Low dose: ≤0.5 mg clonazepam (≤10 mg diazepam equivalents)
  • Moderate dose: 0.5-1.5 mg clonazepam (10-15 mg diazepam equivalents)
  • High dose: >1.5 mg clonazepam (>15 mg diazepam equivalents)

These thresholds are relevant for assessing physical dependence risk and withdrawal potential with chronic use.

Critical Safety Considerations

Avoid abrupt discontinuation: Patients on clonazepam ≥3 months at ≥4 days/week are at significant risk for withdrawal 2. When discontinuing panic disorder treatment, decrease by 0.125 mg twice daily every 3 days 1. For longer-term use, evidence supports reducing by 0.25 mg/week 3.

CNS depression: Clonazepam potentiates effects of opioids, alcohol, other benzodiazepines, and CNS depressants 1. Limit dosage and duration when combining with opioids.

Drug interactions: CYP3A4 inducers (phenytoin, carbamazepine, phenobarbital) decrease clonazepam levels by approximately 38% 1. Monitor phenytoin levels when co-administering 1. Oral antifungals may increase clonazepam concentrations.

Reassessment: Evaluate risk-benefit at least every 3 months for ongoing benzodiazepine prescribing 2.

Common Pitfalls

  • Starting too high: Drowsiness and ataxia are dose-related and occur early 4. Starting low and titrating slowly improves tolerability.
  • Tolerance concerns: While tolerance to anticonvulsant effects has been reported 4, this is not universal and should not preclude appropriate use.
  • Inappropriate use: Do not prescribe for functional seizures without co-occurring epilepsy 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.